Functionally, we suggested that TGFBI affect metastatic potentials of ovarian cancer cells by inducing EMT and remodeling ECM, which might be associated with the activation of integrin αvβ3-PI3K-Akt signaling pathway. Here, TGFBI is linked to ovarian carcinoma.